Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashionWilliam L. Heaton, Michael W. Deininger, Anna V. Senina et al.|Leukemia|2018Cited by 51
Nuclear–Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Michael W. Deininger, Anthony D. Pomicter et al.|Clinical Cancer Research|2018Cited by 40
Abstract 3762: Second generation PIM inhibitors exhibit improved activity in solid tumor modelsJason M. Foulks, Steven B. Kanner, Jihua Liu et al.|Cancer Research|2012Cited by 1
Abstract C200: Second-generation PIM inhibitors exhibit improved activity in solid tumor models in vitro.Jason M. Foulks, Steven B. Kanner, Yong Xu et al.|Molecular Cancer Therapeutics|2011Cited by 1
Supplementary Figure 3 from Nuclear–Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Michael W. Deininger, Anthony D. Pomicter et al.|Unknown|2023Cited by 0